麻豆社

News

Interdisciplinary Consortium Receives Grant to Develop Next-Generation Cell-Based Cancer Vaccines : Med e-News

Published: 19 June 2020

Live 2020 . Saint-Gobain Life Sciences and Kanyr Pharma partner with clinical experts at the Research Institute of 麻豆社 Health Centre and engineers at 麻豆社 to develop new cell culture technologies.

Back to top